We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Ultralife
ULBI
$106M
| $771K | ﹤0.01% |
87,536
-31,579
| -27% | -$257K |
|
|
HONE
2077
DELISTED
HarborOne Bancorp
HONE
| $771K | ﹤0.01% |
+72,301
| New | +$779K |
|
2078
Globant
GLOB
$1.61B
| $767K | ﹤0.01% |
3,800
| – | – |
|
2079
OFS Capital
OFS
$51.9M
| $766K | ﹤0.01% |
77,183
-41,636
| -35% | -$461K |
|
|
AXIA
2080
DELISTED
AXIA Energia
AXIA
| $766K | ﹤0.01% |
115,802
-32,581
| -22% | -$221K |
|
2081
Turning Point Brands
TPB
$1.74B
| $763K | ﹤0.01% |
26,056
+6,571
| +34% | +$167K |
|
2082
CapForce IBD 50 ETF
FFTY
$78.8M
| $763K | ﹤0.01% |
27,600
-6,100
| -18% | -$159K |
|
2083
VistaGen Therapeutics
VTGN
$12.8M
| $762K | ﹤0.01% |
144,386
-47,673
| -25% | -$229K |
|
2084
Redwire
RDW
$3.25B
| $761K | ﹤0.01% |
+173,425
| New | +$551K |
|
2085
Construction Partners
ROAD
$6.77B
| $760K | ﹤0.01% |
13,538
-56,157
| -81% | -$2.65M |
|
2086
Dentsply Sirona
XRAY
$2.43B
| $760K | ﹤0.01% |
22,886
-31,814
| -58% | -$1.09M |
|
2087
Lithia Motors
LAD
$8.26B
| $759K | ﹤0.01% |
+2,524
| New | +$746K |
|
2088
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.88B
| $758K | ﹤0.01% |
19,300
-16,200
| -46% | -$603K |
|
2089
NewtekOne
NEWT
$391M
| $756K | ﹤0.01% |
+68,724
| New | +$810K |
|
2090
FirstService
FSV
$6.32B
| $756K | ﹤0.01% |
4,559
-18,764
| -80% | -$3.1M |
|
|
BCOV
2091
DELISTED
Brightcove, Inc.
BCOV
| $754K | ﹤0.01% |
388,874
-98,241
| -20% | -$216K |
|
|
XIFR
2092
XPLR Infrastructure LP
XIFR
$1.08B
| $752K | ﹤0.01% |
+25,010
| New | +$712K |
|
2093
Globe Life
GL
$14.3B
| $751K | ﹤0.01% |
6,456
-22,453
| -78% | -$2.75M |
|
2094
WisdomTree US SmallCap Earnings Fund
EES
$731M
| $747K | ﹤0.01% |
14,900
+400
| +3% | +$19.2K |
|
2095
Comtech Telecommunications
CMTL
$51.8M
| $743K | ﹤0.01% |
216,580
+115,474
| +114% | +$724K |
|
2096
Village Super Market
VLGEA
$639M
| $740K | ﹤0.01% |
25,873
-3,697
| -13% | -$97.2K |
|
2097
Community Trust Bancorp
CTBI
$1.41B
| $740K | ﹤0.01% |
17,350
+2,211
| +15% | +$90K |
|
2098
Equifax
EFX
$21.4B
| $740K | ﹤0.01% |
+2,765
| New | +$704K |
|
2099
Sotera Health
SHC
$5.38B
| $732K | ﹤0.01% |
60,957
-11,743
| -16% | -$175K |
|
|
LKFT
2100
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $731K | ﹤0.01% |
22,714
+12,588
| +124% | +$468K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.